Dimensional Fund Advisors LP Design Therapeutics, Inc. Transaction History
Dimensional Fund Advisors LP
- $405 Billion
- Q4 2024
A detailed history of Dimensional Fund Advisors LP transactions in Design Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 215,265 shares of DSGN stock, worth $792,175. This represents 0.0% of its overall portfolio holdings.
Number of Shares
215,265
Previous 134,360
60.22%
Holding current value
$792,175
Previous $722,000
83.93%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding DSGN
# of Institutions
103Shares Held
30.5MCall Options Held
2.3KPut Options Held
16.5K-
Sr One Capital Management, LP6.53MShares$24 Million14.99% of portfolio
-
Logos Global Management LP San Francisco, CA4.22MShares$15.5 Million3.0% of portfolio
-
Black Rock Inc. New York, NY2.3MShares$8.48 Million0.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA1.89MShares$6.96 Million0.55% of portfolio
-
Baker Bros. Advisors LP New York, NY1.74MShares$6.42 Million0.1% of portfolio
About Design Therapeutics, Inc.
- Ticker DSGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,807,900
- Market Cap $205M
- Description
- Design Therapeutics, Inc. a preclinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of genetic diseases caused by nucleotide repeat expansions. The company's portfolio of products comprises Friedreich Ataxia, a monogenic, autosomal recessive, progressive multi-system disease that affects organ syste...